QUEEN MARY UNIVERSITY OF LONDON

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1882-01-08

Employees: 1K

Market Cap: -

Website: http://www.qmul.ac.uk

Clinical Trials

Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)

Phase 2

Suspended

Conditions: Multiple Sclerosis
Clinically Isolated Syndrome of Demyelination

Interventions: Drug: Tysabri Injectable Product
Drug: Placebo

First Posted Date: 2022-06-14

Last Posted Date: 2024-11-20

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 40

Registration Number: NCT05418010

Locations: 🇬🇧
Royal London Hospital, London, United Kingdom

Autonomic Neuromodulation by Transcutaneous Nerve Stimulation in Acute Ischaemic Stroke.

Not Applicable

Completed

Conditions: Thrombotic Stroke
Autonomic Dysfunction
Ischemic Stroke
Autonomic Imbalance

Interventions: Device: trans-cutaneous auricular sensory stimulation

First Posted Date: 2022-06-14

Last Posted Date: 2023-08-07

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 36

Registration Number: NCT05417009

Locations: 🇬🇧
William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, United Kingdom

Randomised Trial Comparing Thermal Ablation With Adrenalectomy in the Treatment of Unilateral Asymmetric PA

Not Applicable

Recruiting

Conditions: Primary Aldosteronism

Interventions: Procedure: Thermal ablation of aldosterone producing adenoma.
Procedure: Unilateral adrenalectomy

First Posted Date: 2022-06-06

Last Posted Date: 2024-06-12

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 110

Registration Number: NCT05405101

Locations: 🇬🇧
Cambridge University Hospitals NHS Foundation Trust, Cambridge, Smlg, United Kingdom
🇬🇧
St Bartholomew's Hospital, London, United Kingdom
🇬🇧
University College London Hospital NHS Foundation Trust, London, United Kingdom

and more 3 locations

Investigate and Predict Aortic & Thoracic Surgery Persistenet Postsurgical Pain

Recruiting

Conditions: Persistent Postsurgical Pain

First Posted Date: 2022-05-11

Last Posted Date: 2024-11-21

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 60

Registration Number: NCT05369130

Locations: 🇬🇧
St Bartholomew's Hospital, London, United Kingdom

Measuring Blood Flow in Heart Vessels With a New Fibre Optic Sensor

Not Applicable

Completed

Conditions: Coronary Microvascular Disease
Coronary Artery Disease
Coronary Stenosis

Interventions: Device: Intra coronary rapid-exchange iKOs microcatheter intervention

First Posted Date: 2022-04-26

Last Posted Date: 2024-04-30

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 10

Registration Number: NCT05346458

Locations: 🇬🇧
St Bartholomew's Hospital, London, England, United Kingdom

Implementing Long-Acting Novel Antiretrovirals

Completed

Conditions: Human Immunodeficiency Viruses

Interventions: Other: The Feasibility of Intervention Measure (FIM) and Acceptability of Intervention Measure (AIM)

First Posted Date: 2022-03-24

Last Posted Date: 2024-07-08

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 114

Registration Number: NCT05294159

Locations: 🇬🇧
Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom
🇬🇧
Blizard Institute, London, United Kingdom
🇬🇧
Royal Free Hospital NHS, London, United Kingdom

and more 3 locations

Famciclovir in Multiple Sclerosis

Phase 2

Conditions: Multiple Sclerosis

Interventions: Drug: Famciclovir

First Posted Date: 2022-03-17

Last Posted Date: 2022-03-17

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 30

Registration Number: NCT05283551

Locations: 🇬🇧
Royal London Hospital, Barts Health NHS Trust, London, United Kingdom

Barts Revascularisation Registry

Recruiting

Conditions: Myocardial Infarction
Stable Angina

Interventions: Other: Observation only

First Posted Date: 2022-02-24

Last Posted Date: 2024-07-08

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 20000

Registration Number: NCT05255705

Locations: 🇬🇧
Barts Health NHS Trust, London, United Kingdom

Therapy for Hepatitis C Virus (HCV) in Primary Treatment Failure in Pakistan

Not Applicable

Conditions: Hepatitis C

Interventions: Drug: Epclusa (nucleotide HCV NS5B polymerase inhibitors).

First Posted Date: 2022-02-21

Last Posted Date: 2024-10-21

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 318

Registration Number: NCT05248919

Locations: 🇵🇰
Clinical trials unit, Karachi, Sindh, Pakistan

Arterial Cannulation With Ultrasound

Not Applicable

Terminated

Conditions: Perioperative/Postoperative Complications

Interventions: Procedure: Ultrasound guided arterial cannulation
Procedure: Palpation guided arterial cannulation

First Posted Date: 2022-02-21

Last Posted Date: 2024-08-15

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 57

Registration Number: NCT05249036

Locations: 🇬🇧
Royal London Hospital, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy